CNET [ChinaNet Online] NT 10-Q:
[]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)
[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Weibing Lu, Chief Executive Officer] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Bing Mei, Chief Financial Officer]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q:
[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Weibing Lu, Chief Executive Officer] [(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Bing Mei, Chief Financial Officer]
CLNT [Cleantech Solutions International,] 8-K: (Original Filing)
[Companyntact: Ms. Wanfen Xu Crockerulson Chief Financial Officer CCG Investor Relations Cleantech Solutions International, Tel: +1 646 213 1915 Email: xu_wf@cleantechsolutionsinternational.com Email: Crocker.coulson@ccgir.com, Web: www.cleantechsolutionsinternational.com www.ccgirasia.com Web: Cleantech Solutions International Reports Third Quarter 2012 Results Wuxi, Jiangsu Province, China November 13, 2012 ,ainst a weak macro-economic background, we are very pleased to have achieved 48.5%] [Companyntact: Ms. Wanfen Xu, Chief Financial Officer E-mail: xu_wf@cleantechsolutionsinternational.com Cleantech Solutions International, www.cleantechsolutionsinternational.com Web: Investor Relationsntact: Crockerulson CCG Investor Relations Tel: +1 646 213 1915 crocker.coulson@ccgir.com Email: www.ccgirasia.com Web: Cleantech Solutions International Announcesnferencell to Discuss Third Quarter 2012 Financial Results Wuxi, Jiangsu Province, China November 9, 2012 Cleantech Solutions International,]
CLNT [Cleantech Solutions International,] 8-K: Companyntact: Ms. Wanfen Xu Crockerulson Chief Financial Officer
[Companyntact: Ms. Wanfen Xu Crockerulson Chief Financial Officer CCG Investor Relations Cleantech Solutions International, Tel: +1 646 213 1915 Email: xu_wf@cleantechsolutionsinternational.com Email: Crocker.coulson@ccgir.com, Web: www.cleantechsolutionsinternational.com www.ccgirasia.com Web: Cleantech Solutions International Reports Third Quarter 2012 Results Wuxi, Jiangsu Province, China November 13, 2012 ,ainst a weak macro-economic background, we are very pleased to have achieved 48.5%] [Companyntact: Ms. Wanfen Xu, Chief Financial Officer E-mail: xu_wf@cleantechsolutionsinternational.com Cleantech Solutions International, www.cleantechsolutionsinternational.com Web: Investor Relationsntact: Crockerulson CCG Investor Relations Tel: +1 646 213 1915 crocker.coulson@ccgir.com Email: www.ccgirasia.com Web: Cleantech Solutions International Announcesnferencell to Discuss Third Quarter 2012 Financial Results Wuxi, Jiangsu Province, China November 9, 2012 Cleantech Solutions International,]
CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)
[FORM 10-Q (Mark One) x September 30, 2012 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2012 President and Chief Executive Officer EX-32.1 4 cphi10qex321093012.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 14, 2012 (principal financial officer and principal accounting officer) EX-32.2 5 cphi10qex322093012.htm]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q: SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART
[SKYSTAR BIO-PHARMACEUTICALMPANY FORM10-Q INDEX Page No. 3 PART I.FINANCIAL INFORMATION 4 Item 1.ndensednsolidated Financial Statements 4ndensednsolidated Balance Sheets of September 30, 2012 (Unaudited) and December 31, 2011 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months and Nine Months Ended September 30, 2012 and 2011 (Unaudited)] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THERBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofystar Bio-Pharmaceuticalmpany; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [(2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Weibing Lu, Chief Executive Officer v327445_ex32-1.htm 4 EX-32.1] [(2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Bing Mei, Chief Financial Officer v327445_ex32-2.htm 5 EX-32.2]
RCON [Recon Technology] 10-Q: (Original Filing)
[] [I, Yin Shenping, certify that: (1) I have reviewed this Form 10-Q of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [Certification of Principal Financial Officer I, Liu Jia, certify that: (1) I have reviewed this Form 10-Q of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Recon Technology, Ltd. Yin Shenping] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Recon Technology, Ltd. Liu Jia]
IDI [IDI] 6-K: (Original Filing)
[SEARCHMEDIA HOLDINGS LIMITED (incorporated in the Cayman Islands with limited liability) (NYSE MKT: IDI) Rooms 902 and 903, 500 Weihei Road, Jing An District, Shanghai, China 200041 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN THAT the 2012 annual general meeting of shareholders (the Meeting) of SearchMedia Holdings Limited (the Company) will be held at Rooms 902] [ NOMINEES: PROXY Please mark your votes like this x THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSALS 1-6. FOR AGAINST ABSTAIN 1. To elect Mr. Robert Fried as a director of the Company ¨ ¨ ¨ 2. To elect Mr. Chi-Chuan (Frank) Chen as a director of the Company ¨ ¨ ¨ 3 To elect Mr. Paul] [SearchMedia Holdings Limited]
TPI [TIANYIN PHARMACEUTICAL] 10-Q: FORM 10-Q (Mark One) x For the quarterly
[FORM 10-Q (Mark One) x For the quarterly period ended September 30, 2012 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number,] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended September 30, 2012 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer, Chief Accounting Officer & Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Director]
